Intestinal amoebiasis significantly affects digestive health by causing inflammation and ulceration in the intestines, leading to symptoms such as abdominal pain, diarrhea, and weight loss. The infection, caused by Entamoeba histolytica, disrupts nutrient absorption and can result in severe dehydration if left untreated. Early diagnosis and proper treatment are essential to prevent complications such as liver abscesses. Public health measures like improved sanitation and access to safe drinking water can reduce its spread. For effective treatment and medication availability, reliable mebendazole distributors play a key role in supplying antiparasitic drugs to healthcare providers and pharmacies in affected regions.